Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psyllium Labs is a health technology company focused on developing advanced diagnostic and monitoring tools for gastrointestinal health. The company specializes in non-invasive methods to track gut function and microbiome health, aiming to provide actionable insights for patients suffering from chronic digestive conditions like IBS and IBD. Their primary offering involves a combination of digital health tracking and specialized laboratory analysis to optimize personalized nutrition and treatment plans. By bridging the gap between clinical diagnostics and daily wellness, Psyllium Labs empowers users to manage their digestive health through data-driven interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Psyllium Labs.